| |
| |
|
| Insider
Information: |
Sato Vicki L |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
1,672,571 |
|
|
Indirect Shares
|
8,084 |
|
|
| Direct
Value |
$38,597,849 |
|
|
|
Indirect Value
|
$3,417,754 |
|
|
| Total
Shares |
1,680,655 |
|
|
| Total
Value |
$42,015,603 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
President |
2005-05-11 |
77,233 |
2005-05-11 |
8,084 |
Premium* |
|
|
Perkinelmer Inc |
PKI |
Director |
2017-02-09 |
29,970 |
2004-04-27 |
0 |
Premium* |
|
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2006-09-12 |
11,051 |
2006-09-12 |
0 |
Premium* |
|
|
Borgwarner Inc |
BWA |
Director |
2020-04-29 |
19,823 |
2014-04-30 |
0 |
Premium* |
|
|
Denali Therapeutics Inc. |
DNLI |
Director |
2024-04-15 |
118,043 |
2017-12-12 |
0 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2023-06-30 |
1,315,351 |
|
0 |
Premium* |
|
|
Allogene Therapeutics, Inc. |
ALLO |
|
2023-06-13 |
101,100 |
2021-07-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
226 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 10
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
1,333,351 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,216 |
136,369 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-06-28 |
4 |
AS |
$29.55 |
$49,709 |
D/D |
(1,666) |
134,703 |
0 |
% |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-06-30 |
4 |
AS |
$24.66 |
$443,916 |
D/D |
(18,000) |
1,315,351 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-07-17 |
4 |
AS |
$29.60 |
$49,314 |
D/D |
(1,666) |
133,037 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-08-15 |
4 |
AS |
$24.30 |
$40,484 |
D/D |
(1,666) |
131,371 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-09-15 |
4 |
AS |
$23.60 |
$39,348 |
D/D |
(1,666) |
129,705 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-10-16 |
4 |
AS |
$20.66 |
$34,420 |
D/D |
(1,666) |
128,039 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-11-15 |
4 |
AS |
$19.13 |
$31,871 |
D/D |
(1,666) |
126,373 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-12-15 |
4 |
AS |
$23.39 |
$38,968 |
D/D |
(1,666) |
124,707 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2024-01-16 |
4 |
AS |
$18.42 |
$30,688 |
D/D |
(1,666) |
123,041 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2024-02-15 |
4 |
AS |
$18.37 |
$30,604 |
D/D |
(1,666) |
121,375 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2024-03-15 |
4 |
AS |
$20.10 |
$33,487 |
D/D |
(1,666) |
119,709 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2024-04-15 |
4 |
AS |
$18.29 |
$30,471 |
D/D |
(1,666) |
118,043 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2003-07-02 |
4 |
AS |
$14.58 |
$55,404 |
D/D |
(3,800) |
103,654 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2003-07-02 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
107,454 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2003-07-09 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
107,454 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2003-07-09 |
4 |
AS |
$15.55 |
$59,090 |
D/D |
(3,800) |
103,654 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2003-07-16 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
107,454 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2003-07-16 |
4 |
AS |
$15.99 |
$60,762 |
D/D |
(3,800) |
103,654 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2003-07-23 |
4 |
AS |
$15.70 |
$59,660 |
D/D |
(3,800) |
103,654 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2003-07-23 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
107,454 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2003-07-30 |
4 |
AS |
$14.27 |
$54,226 |
D/D |
(3,800) |
103,654 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2003-07-30 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
107,454 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2003-09-10 |
4 |
OE |
$7.88 |
$27,509 |
D/D |
3,491 |
107,145 |
|
- |
|
226 Records found
|
|
Page 4 of 10 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
